Company intelligence / Profile preview

PIF Equity Partners

Riyadh, Riyadh, Saudi Arabia

Ownership: Private
Employees: ~2000
Development stage: Other

Overview

The Public Investment Fund (PIF) is the sovereign wealth fund of Saudi Arabia and one of the largest such funds in the world. While not a biotechnology company itself, PIF is a major driver of the life sciences sector through its dedicated healthcare investment strategy and the launch of specialized subsidiaries like Lifera. The fund focuses on localizing pharmaceutical manufacturing, enhancing healthcare infrastructure, and investing in global biotech innovation to support Saudi Arabia's Vision 2030. PIF's portfolio includes significant stakes in international healthcare companies and domestic ventures aimed at securing the Kingdom's medical supply chain.

Industry: Investors

Partnerships

SanofiGenDigitalAstraZeneca

Beyond the preview

Go deeper on PIF Equity Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PIF Equity Partners.

Explore the full profile